Regeneron Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ALNY
Alnylam Pharmaceuticals, Inc. |
$233.15 | $19.33 B | -57.65 | 2230 | $2.25 B |
APLS
Apellis Pharmaceuticals, Inc. |
$34.38 | $4.90 B | -11.77 | 705 | $709.95 M |
ARWR
Arrowhead Pharmaceuticals, Inc. |
$19.50 | $2.97 B | -5.65 | 609 | $3.55 M |
BGNE
BeiGene, Ltd. |
$184.71 | $17.07 B | -20.76 | 10600 | $2.46 B |
BMRN
BioMarin Pharmaceutical Inc. |
$67.07 | $15.32 B | 76.12 | 3040 | $2.85 B |
CRSP
CRISPR Therapeutics AG |
$42.43 | $4.91 B | -21.43 | 393 | $35.00 M |
ICPT
Intercept Pharmaceuticals, Inc. |
$19.00 | $794.69 M | -17.43 | 341 | $285.71 M |
IMGN
ImmunoGen, Inc. |
$31.24 | $8.73 B | -111.55 | 277 | $108.78 M |
INCY
Incyte Corporation |
$71.91 | $13.30 B | 17.93 | 2617 | $4.24 B |
IONS
Ionis Pharmaceuticals, Inc. |
$34.10 | $5.69 B | -14.59 | 1069 | $705.14 M |
KRYS
Krystal Biotech, Inc. |
$155.81 | $4.70 B | 75.42 | 275 | $290.52 M |
MDGL
Madrigal Pharmaceuticals, Inc. |
$320.81 | $5.21 B | -10.55 | 528 | $180.13 M |
NTLA
Intellia Therapeutics, Inc. |
$12.80 | $2.19 B | -4.23 | 403 | $57.88 M |
NVO
Novo Nordisk A/S |
$85.03 | $606.41 B | 49.27 | 76302 | $290.40 B |
PTCT
PTC Therapeutics, Inc. |
$45.78 | $2.80 B | -4.75 | 939 | $806.78 M |
RARE
Ultragenyx Pharmaceutical Inc. |
$42.66 | $3.44 B | -5.21 | 1294 | $560.23 M |
RETA
Reata Pharmaceuticals, Inc. |
$172.36 | $6.57 B | -66.29 | 321 | $2.22 M |
RXDX
Prometheus Biosciences, Inc. |
$199.92 | $9.56 B | -56.47 | 97 | $6.81 M |
SRPT
Sarepta Therapeutics, Inc. |
$127.89 | $11.66 B | 286.79 | 1372 | $1.90 B |
UTHR
United Therapeutics Corporation |
$355.39 | $12.20 B | 13.02 | 1305 | $2.88 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
